Food Insecurity Reduction & Strategy Team
This study seeks to address the multifaceted challenges posed by food disparities and their negative consequences on health outcomes, via a comprehensive community health intervention program. Study objectives include: 1. To describe the social-demographic and clinical factors associated with food insecurity in the hospitalized diabetic population. 2. To design, implement and evaluate a nutrition program targeting the hospitalized diabetic population. The investigators will prospectively randomize the target…
Conditions studied
Diabetes Mellitus, Type 2, Food Insecurity, Diabetes Mellitus, Type 1
About this study
This study seeks to address the multifaceted challenges posed by food disparities and their negative consequences on health outcomes, via a comprehensive community health intervention program. Study objectives include: 1. To describe the social-demographic and clinical factors associated with food insecurity in the hospitalized diabetic population. 2. To design, implement and evaluate a nutrition program targeting the hospitalized diabetic population. The investigators will prospectively randomize the target population into either a nutrition program (Intervention), or state-of-art standard of care (SOC) in a 4:1 ratio. Participants in the intervention group will be provided the following two resources in addition to SOC: 1) Enhanced access to nutritious food (twice daily meal delivery up to 90 days post-discharge) 2) Education at discharge and continuing outreach to enhance knowledge for better diet and food options. 3. To enhance community engagement and develop a systematic implementation plan for long-term roll-out of the nutrition program.
Interventions
- Other: Nutrition program — Nutrition program with twice daily meal delivery up to 90 days post-discharge and food and diet education at discharge.
Primary outcomes
- Food insecurity at 60 -days post initial discharge (60 days from discharge)
Eligibility information
Study locations
- Stanford Medicine, Palo Alto, California 94304 United States
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.